Dermata Therapeutics

Dermata is a clinical-stage biotechnology company founded in late 2014, focusing on treating various medical and cosmetic skin conditions as well as diseases with unmet needs, with an emphasis on inflammation and immunology. Our business strategy is to identify and develop innovative products that can quickly progress through clinical trials to demonstrate efficacy and safety for a range of dermatological conditions. The company is currently exploring the use of new chemical entities with novel drug formulations to deliver medications to disease sites for targeted therapy. With investigations into multiple dermatological conditions underway, a strong pipeline has begun to take shape, creating significant value for shareholders.